The Renal Treatment Satisfaction Questionnaire (RTSQ): A measure of satisfaction with treatment for chronic kidney failure

The Renal Treatment Satisfaction Questionnaire (RTSQ): A measure of satisfaction with treatment for chronic kidney failure
复制标题

DOI:
10.1053/j.ajkd.2004.11.010
复制
发表时间:
2005-03-01
影响因子:
13.2
通讯作者:
Bradley, C
Bradley, C
中科院分区:
医学1区
文献类型:
--
作者:
Barendse, SM;Speight, J;Bradley, C

文献摘要

被引文献

相似文献

背景:通过使用针对具体情况的治疗满意度措施,可以提高护理的质量和有效性。本研究的目的是设计和开发一种慢性肾衰竭(CKF)患者治疗满意度的测量方法,用于常规临床护理和临床试验。肾脏治疗满意度问卷(RTSQ)的设计适用于使用各种CKF治疗方式的患者。项目衡量对治疗方面的满意度,包括便利性、灵活性、自由度和继续目前形式治疗的满意度。方法:在英国一家医院肾科调查了一项12项RTSQ,使用140名接受肾脏替代治疗的门诊患者的数据(血液透析,n = 35;连续动态腹膜透析,n = 57;移植,n = 46)。结果:由原来的12项量表发展为11项量表,单因素占方差的59%,项目负荷大于0.58。量表在整个样本中具有优异的信度(a = 0.93),并且在单独的治疗亚组中具有稳健性。正如预期的那样,RTSQ评分在移植组和其他治疗组之间差异显著(P < 0.0001)。接受移植的患者表现出更大的总体满意度,移植的具体优势体现在所有个人项目上,包括便利、时间、生活方式、自由和继续当前治疗的满意度。结论:RTSQ为CK:F患者提供了一种简单可靠的治疗满意度测量方法,适用于常规临床护理和临床试验。
Background: Quality and effectiveness of care can be enhanced through the use of condition-specific measures of satisfaction with treatment. The aim of the present study was to design and develop a measure of satisfaction with treatment for patients with chronic kidney failure (CKF) for use in routine clinical care and clinical trials. The Renal Treatment Satisfaction Questionnaire (RTSQ) was designed to be suitable for people using any of the various treatment modalities for CKF. Items measure satisfaction with aspects of treatment, including convenience, flexibility, freedom, and satisfaction to continue with present form of treatment. Methods: A 12-item RTSQ was investigated at a UK hospital-based renal unit, using data from 140 outpatients undergoing renal replacement therapy (hemodialysis, n = 35; continuous ambulatory peritoneal dialysis, n = 57; transplantation, n = 46). Results: An 11-item scale was developed from the original 12-item version, with a single factor accounting for 59% of the variance and item loadings greater than 0.58. Scale reliability was excellent (a = 0.93) in the full sample and proved robust to analysis in separate treatment subgroups. As expected, RTSQ scores differed significantly (P < 0.0001) between the transplantation and other treatment groups. Those who had received a transplant expressed greater overall satisfaction, with specific advantages of transplantation shown by all individual items, including convenience, time, lifestyle, freedom, and satisfaction to continue current treatment. Conclusion: The RTSQ provides a brief reliable measure of satisfaction with treatment for patients with CK:F that is suitable for use in routine clinical care and clinical trials.